Fed. Circ. Nixes Abraxis Win In Naropin Patent Row
A federal appeals court has overturned a lower court's ruling that generic-drug maker Navinta LLC infringed three patents for Abraxis BioScience Inc.'s injectable pain management drug Naropin....To view the full article, register now.
Already a subscriber? Click here to view full article